Skip to main content
  1. Home
  2. Emerging Tech
  3. Web
  4. News

Google has a plan to stop its top talent jumping ship

Add as a preferred source on Google

So it seems Google’s top brass has had enough of its employees walking out the door as soon as they come up with an awesome startup idea.

There’s no publicly available data on how often this actually happens, but the fact that Google now has a plan to stop them leaving suggests that holding on to talent has become a real issue for the company.

Recommended Videos

The strategy? Launch an incubator within Google so entrepreneur-minded employees can pitch their ideas directly to the company.

Area 120

Called “Area 120,” the setup will be led by long-time Google executives Don Harrison and Bradley Horowitz, The Information reported after speaking to insiders with knowledge of the matter.

The plan is to encourage Googlers with startup ideas to submit an outline of their project to Area 120. If the proposal gets the green light, the team can work on it full-time for several months to take it to the next level.

The next step will be to pitch the developed plan to Google with the aim of securing funding. Should the Web giant be suitably impressed, it’ll support the creation of a full-fledged startup and even invest in it.

The name of the initiative appears to be a nod to the company’s long-running “20 percent time” scheme that lets employees spend 20 percent of their working hours tinkering with personal projects.

Google believes the scheme empowers its workers “to be more creative and innovative,” and claims it’s led the company to many “significant advances” over the years.

Now it just wants to make sure that when great ideas pop into the minds of its talented team, they don’t make a beeline for the exit to either launch their plan independently or take it to a competing firm.

Google hasn’t confirmed the existence of Area 120, but the idea makes sense on several levels. Besides keeping talent inside the company, it’d also prevent a competitor getting its hands on a promising – or later, successful – startup. As for Googlers looking to take a proposal for a spin, Area 120 sounds like it’ll provide not only the financial support and working hours for the plan’s development, but also the job security as they work to see if their ambitious plan really has legs.

Trevor Mogg
Contributing Editor
Not so many moons ago, Trevor moved from one tea-loving island nation that drives on the left (Britain) to another (Japan)…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more